ANI Pharmaceuticals, Inc. (ANIP)
77.77
-0.33
(-0.42%)
USD |
NASDAQ |
Feb 20, 16:00
77.78
+0.01
(+0.01%)
After-Hours: 20:00
ANI Pharmaceuticals SG&A Expense (Quarterly) : 76.66M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| CorMedix, Inc. | 36.64M |
| Castle Biosciences, Inc. | 55.91M |
| Arcutis Biotherapeutics, Inc. | 62.40M |
| Amicus Therapeutics, Inc. | 117.08M |
| Capricor Therapeutics, Inc. | 5.925M |